Euroimmun US - A world leader in the field of medical diagnostics

(800) 913-2022 | Contact Product Finder

Home redesign

Revvity

Revvity

Working together to support healthier lives.

Company Profile

Global leader in diagnostics, innovating autoimmune, infectious disease, and beyond.

Pattern IQ

Pattern IQ

Learn ANA patterns, test knowledge, and earn PACE® credits free.

Euroimmun Academy

Euroimmun Academy

Free webinars, expert insights, and diagnostics learning.

Euroimmun US News

July 29, 2025

Euroimmun Unveils New Visual Identity at ADLM 2025

April 2, 2025

Revvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test

September 19, 2024

Oropouche Virus Disease Among U.S. Travelers – United States, 2024

April 29, 2024

The subsidiary ProciseDx announces distribution agreement with Revvity’s EUROIMMUN US for the distribution of the ProciseDx platform in the United State and Canada

March 22, 2023

EUROIMMUN Wins 2023 New Jersey Top Workplaces Award

June 24, 2021

SARS-CoV-2 Variants of Concern (VOC) Alpha, Beta, Gamma and Delta

April 17, 2020

ABC News: Largest antibody study could answer crucial coronavirus questions

November 20, 2018

Membranous Nephropathy: Antibody-based diagnosis, prognosis, and disease monitoring

February 27, 2018

Measles and Mumps Forgotten Diseases of Recurring Relevance

July 27, 2017

Autoimmune Encephalitis – Anti NMDAR and Beyond

April 12, 2017

EUROIMMUN Announces Option Agreement with Roche on Zika Virus Serology

May 28, 2016

EUROIMMUN CEO Interviewed by Clinical Lab Products in regard to Zika virus

April 19, 2016

Zika Virus: Anatomy of a Global Health Crisis

February 17, 2016

First Commercial Serological Tests Available for Zika Virus Detection

2025 Euroimmun US

Privacy Policy | Website Terms and Conditions | Cookie Notice and Settings | Consent Preferences | Sitemap